List view / Grid view
2 April 2015 | By Victoria White
Ocera has announced successful completion of a planned interim analysis of its OCR-002 STOP-HE study in patients with acute HE...
2 April 2015 | By Victoria White
OncoMed has entered into an agreement with Lilly. Demcizumab is being tested in combination with Alimta and carboplatin for the treatment of NSCLC...
2 April 2015 | By Victoria White
SAGE Therapeutics has announced details of its planned SAGE-547 global Phase 3 development programme for the treatment of patients with SRSE.
2 April 2015 | By Victoria White
pSivida has announced the completion of the targeted enrollment of 120 patients in its pivotal Phase III clinical trial of Medidur for posterior uveitis...
2 April 2015 | By Victoria White
Conatus has announced top-line results from the Phase 2 clinical trial of emricasan, a first-in-class, orally active pan-caspase protease inhibitor...
2 April 2015 | By Victoria White
Proteon has announced positive results from a long-term analysis of follow-up data from a Phase 2 study of its lead candidate, vonapanitase...
2 April 2015 | By Victoria White
Idera has announced that the FDA has granted orphan drug designation for IMO-8400 for the treatment of diffuse large B-cell lymphoma (DLBCL)...
1 April 2015 | By Victoria White
Peregrine has announced promising clinical data from a Phase I trial evaluating bavituximab therapy in patients with metastatic breast cancer...
1 April 2015 | By Victoria White
Three-month paliperidone palmitate significantly delayed time to relapse compared to placebo in patients with schizophrenia, according to a Phase 3 study...
1 April 2015 | By Victoria White
Kala has announced positive results from a Phase 3 clinical trial of KPI-121 for the treatment of patients who have undergone cataract surgery...
1 April 2015 | By Victoria White
InVivo has announced a new clinical site in the ongoing IDE pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury...
1 April 2015 | By Victoria White
"MODHEP: Understanding liver cancer" shown at European Parliament to delegates at an event celebrating collaboration between the EU and other countries...
1 April 2015 | By Victoria White
The US treatment market for Rheumatoid Arthritis is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, says GBI Research...
1 April 2015 | By Victoria White
NeuroDerm has announced that updated results from the Phase II Study of ND0612L will be presented at the American Academy of Neurology 67th Annual Meeting...
1 April 2015 | By Victoria White
BioCryst has announced it has been has awarded a contract for the continued development of BCX4430 as a potential treatment for diseases, including Ebola...
